Essex In the News

BIRMINGHAM, Ala.—MEDSEEK, the leading provider of online strategic patient engagement and analytics solutions for healthcare organizations, announced today that Silver Lake Sumeru, Essex Woodlands and MEDSEEK management have signed a definitive agreement to acquire the Company. MEDSEEK’s software platform helps healthcare organizations attract and retain patients and improves patient experience…  

HOUSTON, Texas – Essex Woodlands (www.ewhv.com), a global healthcare growth equity and venture capital firm, announced today the launch of Bioventus LLC, a strategic partnership with Smith & Nephew, the largest UK-based medical device company.

Headquartered in Durham, N.C., Bioventus is Smith & Nephew’s former Biologics Division/Clinical Therapies business that…  

DEERFIELD, IL—Horizon Pharma, Inc. today announced that the Annals of the Rheumatic Diseases has published results from the CAPRA-2 (Circadian Administration of Prednisone in Rheumatoid Arthritis-2) U.S. registration study, which demonstrated that patients with active rheumatoid arthritis (RA) treated with RAYOS® in addition to ongoing disease-modifying anti-rheumatic drug (DMARD) therapy…  

NEWARK, California   — Oraya Therapeutics, Inc. today announced that the INTREPID clinical trial of radiation therapy has met its primary endpoint of reduction in anti-VEGF injections for patients with wet age-related macular degeneration (wet AMD).  The INTREPID study is the first sham-controlled double-masked trial to evaluate the effectiveness and…  

Essex Woodlands Health Ventures will distribute more than $200 million as a result of the $650 million sale of portfolio holding EUSA Pharma Inc., a company it launched by teaming up with entrepreneur Bryan Morton.

EUSA is merging with publicly traded Jazz Pharmaceuticals PLC in a $650 million cash…